United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma

Faith E. Davies(NYU Langone Health), Steve Schey(King's College London), Craig Williams(The University of Adelaide), Gordon Cook(University of Leeds), Curly Morris(Belfast Health and Social Care Trust), Jack Tighe(Aberdeen Royal Infirmary), Gareth J. Morgan(Hywel Dda University Health Board), Judith Behrens(National Health Service), Jenny Bird, Jamie Cavenagh(St Bartholomew's Hospital)
International Journal of Laboratory Hematology
November 4, 2008
10.1111/j.1751-553x.2008.01106.x
Cited by 1

Related Papers

The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3.1k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k